Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT) and Invivyd (IVVD)
TipRanksApr 9 00:10
Invivyd Analyst Ratings
BenzingaApr 5 20:12
Invivyd Receives Upgrade to Overweight From Equalweight From Morgan Stanley, Price Target Raised to $10 From $4 Amid Pemgarda FDA Authorization
MT NewswiresMar 26 19:13
Invivyd Analyst Ratings
BenzingaMar 26 17:26
Morgan Stanley Upgrades Invivyd to Overweight, Raises Price Target to $10
BenzingaMar 26 17:28
Invivyd's PEMGARDA: Strong Buy Rating on FDA EUA and Strategic Market Positioning
TipRanksMar 25 21:05
Invivyd Analyst Ratings
BenzingaMar 25 20:57
HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $15 Price Target
BenzingaMar 25 20:59
Invivyd Analyst Ratings
BenzingaJan 18 19:14
Invivyd Analyst Ratings
BenzingaDec 19, 2023 22:09
Analysts' Opinions Are Mixed on These Healthcare Stocks: NeuroOne Medical Technologies (NMTC), Invivyd (IVVD) and Ligand Pharma (LGND)
TipRanksDec 18, 2023 22:31
Buy Rating for Invivyd Due to Promising COVID-19 Therapy VYD222 and High Market Potential for Immunocompromised Populations
TipRanksNov 11, 2023 01:46
HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $5 Price Target
BenzingaAug 14, 2023 18:21
Invivyd Analyst Ratings
BenzingaAug 14, 2023 18:19
HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $5 Price Target
BenzingaJul 18, 2023 16:13
Invivyd Analyst Ratings
BenzingaJul 18, 2023 16:12
H.C. Wainwright Remains a Buy on Invivyd (IVVD)
TipRanksJul 17, 2023 22:55
H.C. Wainwright Sticks to Its Buy Rating for Invivyd (IVVD)
TipRanksJun 28, 2023 20:35
What 4 Analyst Ratings Have To Say About Invivyd
BenzingaJun 23, 2023 23:01
Analysts Offer Insights on NA Companies: Invivyd (IVVD) and ISun (ISUN)
TipRanksJun 23, 2023 18:20
No Data
No Data